Gabriele Vicedomini

Gabriele Vicedomini

Auto-generated profile, based on publicly available information

Gabriele Vicedomini

Department of Arrhythmology, IRCCS Policlinico San Donato, San Donato Milanese, Milano, Italy

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2000 in Circulation
Verified
Journal Article
Closed access
CPCarlo Pappone
Carlo Pappone
SRSalvatore Rosanio
Salvatore Rosanio
GOGiuseppe Oreto
Giuseppe Oreto
MTMonica Tocchi
Monica Tocchi
FGFilippo Gugliotta
Filippo Gugliotta
SCSergio Chierchia
Sergio Chierchia
Background —The pulmonary veins (PVs) and surrounding ostial areas frequently house focal triggers or reentrant circuits critical to the genesis of atrial fibrillation (AF). We developed an anatomic approach aimed at isolating each PV from the left atrium (LA) by circumferential radiofrequency (RF) lesions around their ostia. Methods and Results —We selected 26 patients with resistant AF, either paroxysmal (n=14) or permanent (n=12). A nonfluoroscopic mapping system was used to generate 3D electroanatomic LA maps and deliver RF energy. Two maps were acquired during coronary sinus and right atrial pacing to validate the lateral and septal PV lesions, respectively. Patients were followed up closely for ≥6 months. Procedures lasted 290±58 minutes, including 80±22 minutes for acquisition of all maps, and 118±16 RF pulses were deployed. Among 14 patients in AF at the beginning of the procedure, 64% had sinus rhythm restoration during ablation. PV isolation was demonstrated in 76% of 104 PVs treated by low peak-to-peak electrogram amplitude (0.08±0.02 mV) inside the circular line and by disparity in activation times (58±11 ms) across the lesion. After 9±3 months, 22 patients (85%) were AF-free, including 62% not taking and 23% taking antiarrhythmic drugs, with no difference ( P =NS) between paroxysmal and permanent AF. No thromboembolic events or PV stenoses were observed by transesophageal echocardiography. Conclusions —Radiofrequency PV isolation with electroanatomic guidance is safe and effective in either paroxysmal or permanent AF.

27 January 2004 in Circulation
Verified
Journal Article
Closed access
PDF file
CPCarlo Pappone
Carlo Pappone
VSVincenzo Santinelli
Vincenzo Santinelli
FMFrancesco Manguso
Francesco Manguso
GVGabriele Vicedomini
Gabriele Vicedomini
FGFilippo Gugliotta
Filippo Gugliotta
OAOttavio Alfieri
Ottavio Alfieri
Background— There are no data to evaluate the relationship between autonomic nerve function modification and recurrent atrial fibrillation (AF) after circumferential pulmonary vein ablation (CPVA). This study assesses the incremental benefit of vagal denervation by radiofrequency in preventing recurrent AF in a large series of patients undergoing CPVA for paroxysmal AF. Methods and Results— Data were collected on 297 patients undergoing CPVA for paroxysmal AF. Abolition of all evoked vagal reflexes around all pulmonary vein ostia was defined as complete vagal denervation (CVD) and was obtained in 34.3% of patients. Follow-up ended at 12 months. Heart rate variability attenuation, consistent with vagal withdrawal, was detectable for up to 3 months after CPVA, particularly in patients with reflexes and CVD, who were less likely to have recurrent AF than those without reflexes ( P =0.0002, log-rank test). Only the percentage area of left atrial isolation and CVD were predictors of AF recurrence after CPVA ( P <0.001 and P =0.025, respectively). Conclusions— This study suggests that adjunctive CVD during CPVA significantly reduces recurrence of AF at 12 months.

2 March 2006 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
HOHakan Oral
Hakan Oral
CPCarlo Pappone
Carlo Pappone
ACAman Chugh
Aman Chugh
EGEric Good
Eric Good
FBFrank Bogun
Frank Bogun
FMFred Morady
Fred Morady
We conducted a randomized, controlled trial of circumferential pulmonary-vein ablation for the treatment of chronic atrial fibrillation. A total of 146 patients with a mean (±SD) age of 57±9 years who had chronic atrial fibrillation were randomly assigned to receive amiodarone and undergo two cardioversions during the first three months alone (the control group) or in combination with circumferential pulmonary-vein ablation. Cardiac rhythm was assessed with daily telephonic transmissions for one year. The left atrial diameter and the severity of symptoms were assessed at 12 months. Among the 77 patients assigned to undergo circumferential pulmonary-vein ablation, ablation was repeated because of recurrent atrial fibrillation in 26 percent of patients and atypical atrial flutter in 6 percent. An intention-to-treat analysis showed that 74 percent of patients in the ablation group and 58 percent of those in the control group were free of recurrent atrial fibrillation or flutter without antiarrhythmic-drug therapy at one year (P=0.05). Among the 69 patients in the control group, 53 (77 percent) crossed over to undergo circumferential pulmonary-vein ablation for recurrent atrial fibrillation by one year and only 3 (4 percent) were in sinus rhythm without antiarrhythmic-drug therapy or ablation. There were significant decreases in the left atrial diameter (12±11 percent, P<0.001) and the symptom severity score (59±21 percent, P<0.001) among patients who remained in sinus rhythm after circumferential pulmonary-vein ablation. Except for atypical atrial flutter, there were no complications attributable to circumferential pulmonary-vein ablation. Sinus rhythm can be maintained long term in the majority of patients with chronic atrial fibrillation by means of circumferential pulmonary-vein ablation independently of the effects of antiarrhythmic-drug therapy, cardioversion, or both. The maintenance of sinus rhythm is associated with a significant decrease in both the severity of symptoms and the left atrial diameter.

8 June 2004 in Circulation
Verified
Journal Article
Closed access
CPCarlo Pappone
Carlo Pappone
HOHakan Oral
Hakan Oral
VSVincenzo Santinelli
Vincenzo Santinelli
GVGabriele Vicedomini
Gabriele Vicedomini
CLChristopher C. Lang
Christopher C. Lang
FMFred Morady
Fred Morady
Background— Radiofrequency ablation for atrial fibrillation is becoming widely practiced. Methods and Results— Two patients undergoing circumferential pulmonary vein ablation for atrial fibrillation in different centers developed symptoms compatible with endocarditis 3 to 5 days after the procedure. Their clinical condition deteriorated rapidly, and both suffered multiple gaseous and/or septic embolic events causing cerebral and myocardial damage. One patient survived after emergency cardiac and esophageal surgery; the other died of extensive systemic embolization. An atrio-esophageal fistula was identified in both patients. Conclusions— Atrio-esophageal fistulas can occur after catheter ablation in the posterior wall of the left atrium. This diagnosis should be excluded in any patient with symptoms or signs of endocarditis after left atrial ablation, and expeditious cardiac surgery is critical if the diagnosis is confirmed. Lower power and temperature settings for applications of radiofrequency energy along the posterior left atrial wall may prevent further cases of fistula formation.

20 November 2001 in Circulation
Verified
Journal Article
Closed access
PDF file
CPCarlo Pappone
Carlo Pappone
GOGiuseppe Oreto
Giuseppe Oreto
SRSalvatore Rosanio
Salvatore Rosanio
GVGabriele Vicedomini
Gabriele Vicedomini
MTMonica Tocchi
Monica Tocchi
OAOttavio Alfieri
Ottavio Alfieri
Background Circumferential radiofrequency ablation around pulmonary vein (PV) ostia has recently been described as a new anatomic approach for atrial fibrillation (AF). Methods and Results We treated 251 consecutive patients with paroxysmal (n=179) or permanent (n=72) AF. Circular PV lesions were deployed transseptally during sinus rhythm (n=124) or AF (n=127) using 3D electroanatomic guidance. Procedures lasted 148±26 minutes. Among 980 lesions surrounding individual PVs (n=956) or 2 ipsilateral veins with close openings or common ostium (n=24), 75% were defined as complete by a bipolar electrogram amplitude 30 ms across the line. The amount of low-voltage encircled area was 3594±449 mm 2 , which accounted for 23±9% of the total left atrial (LA) map surface. Major complications (cardiac tamponade) occurred in 2 patients (0.8%). No PV stenoses were detected by transesophageal echocardiography. After 10.4±4.5 months, 152 patients with paroxysmal AF (85%) and 49 with permanent AF (68%) were AF-free. Patients with and without AF recurrence did not differ in age, AF duration, prevalence of heart disease, or ejection fraction, but the LA diameter was significantly higher ( P <0.001) in permanent AF patients with recurrence. The proportion of PVs with complete lesions was similar between patients with and without recurrence, but the latter had larger low-voltage encircled areas after radiofrequency (expressed as percent of LA surface area; P <0.001). Conclusions Circumferential PV ablation is a safe and effective treatment for AF. Its success is likely due to both PV trigger isolation and electroanatomic remodeling of the area encompassing the PV ostia.

1 July 2003 in JACC
Verified
Journal Article
Closed access
CPCarlo Pappone
Carlo Pappone
SRSalvatore Rosanio
Salvatore Rosanio
GAGiuseppe Augello
Giuseppe Augello
GGGiuseppe Gallus
Giuseppe Gallus
GVGabriele Vicedomini
Gabriele Vicedomini
OAOttavio Alfieri
Ottavio Alfieri